NAYAX LTD (NYAX) Fundamental Analysis & Valuation

NASDAQ:NYAX • IL0011751166

Current stock price

61.21 USD
-0.12 (-0.2%)
Last:

This NYAX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. NYAX Profitability Analysis

1.1 Basic Checks

  • NYAX had positive earnings in the past year.
  • NYAX had a positive operating cash flow in the past year.
  • In the past 5 years NYAX reported 4 times negative net income.
  • In multiple years NYAX reported negative operating cash flow during the last 5 years.
NYAX Yearly Net Income VS EBIT VS OCF VS FCFNYAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • NYAX's Return On Assets of 4.17% is fine compared to the rest of the industry. NYAX outperforms 65.32% of its industry peers.
  • NYAX has a Return On Equity of 15.37%. This is amongst the best in the industry. NYAX outperforms 85.48% of its industry peers.
  • The Return On Invested Capital of NYAX (3.71%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.17%
ROE 15.37%
ROIC 3.71%
ROA(3y)-0.68%
ROA(5y)-5.96%
ROE(3y)-1.44%
ROE(5y)-11.79%
ROIC(3y)N/A
ROIC(5y)N/A
NYAX Yearly ROA, ROE, ROICNYAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.87%, NYAX belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
  • NYAX has a better Operating Margin (6.82%) than 69.35% of its industry peers.
  • NYAX has a Gross Margin of 48.19%. This is amongst the best in the industry. NYAX outperforms 83.06% of its industry peers.
  • In the last couple of years the Gross Margin of NYAX has remained more or less at the same level.
Industry RankSector Rank
OM 6.82%
PM (TTM) 8.87%
GM 48.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.67%
GM growth 5Y0.42%
NYAX Yearly Profit, Operating, Gross MarginsNYAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

7

2. NYAX Health Analysis

2.1 Basic Checks

  • NYAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NYAX has been increased compared to 1 year ago.
  • The number of shares outstanding for NYAX has been increased compared to 5 years ago.
  • NYAX has a better debt/assets ratio than last year.
NYAX Yearly Shares OutstandingNYAX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
NYAX Yearly Total Debt VS Total AssetsNYAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 3.21 indicates that NYAX is not in any danger for bankruptcy at the moment.
  • NYAX has a Altman-Z score of 3.21. This is comparable to the rest of the industry: NYAX outperforms 50.81% of its industry peers.
  • The Debt to FCF ratio of NYAX is 1.10, which is an excellent value as it means it would take NYAX, only 1.10 years of fcf income to pay off all of its debts.
  • NYAX has a better Debt to FCF ratio (1.10) than 84.68% of its industry peers.
  • NYAX has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.13, NYAX is in line with its industry, outperforming 49.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.1
Altman-Z 3.21
ROIC/WACC0.43
WACC8.56%
NYAX Yearly LT Debt VS Equity VS FCFNYAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • NYAX has a Current Ratio of 2.26. This indicates that NYAX is financially healthy and has no problem in meeting its short term obligations.
  • NYAX has a Current ratio (2.26) which is comparable to the rest of the industry.
  • NYAX has a Quick Ratio of 2.16. This indicates that NYAX is financially healthy and has no problem in meeting its short term obligations.
  • NYAX has a Quick ratio (2.16) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 2.16
NYAX Yearly Current Assets VS Current LiabilitesNYAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

8

3. NYAX Growth Analysis

3.1 Past

  • NYAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 581.48%, which is quite impressive.
  • The Revenue has grown by 27.52% in the past year. This is a very strong growth!
  • NYAX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.43% yearly.
EPS 1Y (TTM)581.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%629.17%
Revenue 1Y (TTM)27.52%
Revenue growth 3Y32.15%
Revenue growth 5Y38.43%
Sales Q2Q%34.28%

3.2 Future

  • Based on estimates for the next years, NYAX will show a very strong growth in Earnings Per Share. The EPS will grow by 33.11% on average per year.
  • The Revenue is expected to grow by 24.86% on average over the next years. This is a very strong growth
EPS Next Y12.46%
EPS Next 2Y33.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year28.11%
Revenue Next 2Y24.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NYAX Yearly Revenue VS EstimatesNYAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
NYAX Yearly EPS VS EstimatesNYAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

2

4. NYAX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 78.47, NYAX can be considered very expensive at the moment.
  • NYAX's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.33. NYAX is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 69.78, the valuation of NYAX can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as NYAX.
  • NYAX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 38.16.
Industry RankSector Rank
PE 78.47
Fwd PE 69.78
NYAX Price Earnings VS Forward Price EarningsNYAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYAX is on the same level as its industry peers.
  • NYAX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 64.1
EV/EBITDA 37.1
NYAX Per share dataNYAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NYAX does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as NYAX's earnings are expected to grow with 33.11% in the coming years.
PEG (NY)6.3
PEG (5Y)N/A
EPS Next 2Y33.11%
EPS Next 3YN/A

0

5. NYAX Dividend Analysis

5.1 Amount

  • No dividends for NYAX!.
Industry RankSector Rank
Dividend Yield 0%

NYAX Fundamentals: All Metrics, Ratios and Statistics

NAYAX LTD

NASDAQ:NYAX (4/15/2026, 11:36:08 AM)

61.21

-0.12 (-0.2%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-09
Earnings (Next)05-11
Inst Owners23.02%
Inst Owner Change0%
Ins Owners58.51%
Ins Owner Change-0.03%
Market Cap2.24B
Revenue(TTM)400.43M
Net Income(TTM)35.52M
Analysts84.44
Price Target0.7 (-98.86%)
Short Float %0.12%
Short Ratio1.28
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.33%
Min EPS beat(2)-59.91%
Max EPS beat(2)37.25%
EPS beat(4)2
Avg EPS beat(4)37.17%
Min EPS beat(4)-59.91%
Max EPS beat(4)217.85%
EPS beat(8)3
Avg EPS beat(8)-101.11%
EPS beat(12)6
Avg EPS beat(12)-73.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.32%
Min Revenue beat(2)-6.72%
Max Revenue beat(2)-1.92%
Revenue beat(4)0
Avg Revenue beat(4)-5.23%
Min Revenue beat(4)-7.09%
Max Revenue beat(4)-1.92%
Revenue beat(8)0
Avg Revenue beat(8)-5.94%
Revenue beat(12)1
Avg Revenue beat(12)-4.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.4%
PT rev (3m)9.35%
EPS NQ rev (1m)-10%
EPS NQ rev (3m)-10%
EPS NY rev (1m)-1.15%
EPS NY rev (3m)-1.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.12%
Revenue NY rev (1m)3.73%
Revenue NY rev (3m)4.01%
Valuation
Industry RankSector Rank
PE 78.47
Fwd PE 69.78
P/S 5.6
P/FCF 64.1
P/OCF 55.62
P/B 9.7
P/tB 55.3
EV/EBITDA 37.1
EPS(TTM)0.78
EY1.27%
EPS(NY)0.88
Fwd EY1.43%
FCF(TTM)0.95
FCFY1.56%
OCF(TTM)1.1
OCFY1.8%
SpS10.94
BVpS6.31
TBVpS1.11
PEG (NY)6.3
PEG (5Y)N/A
Graham Number10.5235 (-82.81%)
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 15.37%
ROCE 4.72%
ROIC 3.71%
ROICexc 8.27%
ROICexgc 30.71%
OM 6.82%
PM (TTM) 8.87%
GM 48.19%
FCFM 8.73%
ROA(3y)-0.68%
ROA(5y)-5.96%
ROE(3y)-1.44%
ROE(5y)-11.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.67%
GM growth 5Y0.42%
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.1
Debt/EBITDA 0.56
Cap/Depr 20.91%
Cap/Sales 1.33%
Interest Coverage 3.78
Cash Conversion 76.32%
Profit Quality 98.43%
Current Ratio 2.26
Quick Ratio 2.16
Altman-Z 3.21
F-Score7
WACC8.56%
ROIC/WACC0.43
Cap/Depr(3y)13.4%
Cap/Depr(5y)18.73%
Cap/Sales(3y)0.86%
Cap/Sales(5y)1.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)581.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%629.17%
EPS Next Y12.46%
EPS Next 2Y33.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.52%
Revenue growth 3Y32.15%
Revenue growth 5Y38.43%
Sales Q2Q%34.28%
Revenue Next Year28.11%
Revenue Next 2Y24.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y432.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year119.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.09%
OCF growth 3YN/A
OCF growth 5Y44.08%

NAYAX LTD / NYAX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NAYAX LTD (NYAX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NYAX.


Can you provide the valuation status for NAYAX LTD?

ChartMill assigns a valuation rating of 2 / 10 to NAYAX LTD (NYAX). This can be considered as Overvalued.


What is the profitability of NYAX stock?

NAYAX LTD (NYAX) has a profitability rating of 5 / 10.


Can you provide the financial health for NYAX stock?

The financial health rating of NAYAX LTD (NYAX) is 7 / 10.